Dr. Hochberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yaw 7B
Boston, MA 02114Phone+1 617-724-4000Fax+1 617-724-6801
Summary
- Dr. Ephraim Hochberg is an oncologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from Case Western Reserve University School of Medicine and has been in practice 21 years. He specializes in hematologic oncology and is experienced in Hodgkin Lymphoma and Non-hodgkin Lymphoma. He has more than 100 publications and over 500 citings.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
- Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
- Case Western Reserve University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 1998 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2022
- Boston Magazine Castle Connolly, 2010-2013
- America's Top Doctors for Cancer Castle Connolly, 2010-2013
- Join now to see all
Clinical Trials
- CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma Start of enrollment: 2006 Dec 01
- Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma Start of enrollment: 2012 Aug 16
Publications & Presentations
PubMed
- Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis.Leon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, Jeremy S Abramson, Maria Martinez-Lage
American Journal of Hematology. 2024-12-01 - Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.Ronald Nemec, Marielle Scherrer-Crosbie, Jeremy S Abramson, Robert Redd, Hannah K Gilman
Leukemia & Lymphoma. 2024-06-01 - 3 citationsFive-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.Inhye E Ahn, Danielle M Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva
Blood Advances. 2024-02-27
Journal Articles
- Pilot Randomized Trial of an Electronic Symptom Monitoring Intervention for Hospitalized Patients with CancerE P Hochberg, D P Ryan, J S Temel, V A Jackson, J A Greer, Annals of Oncology
Press Mentions
- $1 Million Gift to Mass General Cancer Center Will Support Promising Research Conducted by Pioneering Physician-ScientistsOctober 21st, 2024
- Case 31-2020: A 48-Year-Old Man with Lymphoma and Abdominal PainOctober 8th, 2020
- A New Cancer Care Dilemma: Patients Want Immunotherapy Even When Evidence Is LackingJune 4th, 2018
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: